Cilnidipine is a dihydropyridine calcium channel blocker primarily used as an antihypertensive agent to manage high blood pressure. Pharmaceutical laboratories utilize this category of reference standards… Read more



![Chemical structure of 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, 3-(2-methoxyethyl) 5-[(2E)-3-phenyl-2-propen-1-yl] Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2564740-92-5-35-Pyridinedicarboxylic-acid-14-dihydro-26-dimethyl-4-2-nitrophenyl-3-2-methoxyethyl-5-2E-3-phenyl-2-propen-1-yl-Ester.png&w=3840&q=75)
![Chemical structure of 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(4-nitrophenyl)-, 3-(2-methoxyethyl) 5-[(2E)-3-phenyl-2-propen-1-yl] Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2564740-95-8-35-Pyridinedicarboxylic-acid-14-dihydro-26-dimethyl-4-4-nitrophenyl-3-2-methoxyethyl-5-2E-3-phenyl-2-propen-1-yl-Ester.png&w=3840&q=75)















Cilnidipine is a dihydropyridine calcium channel blocker primarily used as an antihypertensive agent to manage high blood pressure. Pharmaceutical laboratories utilize this category of reference standards to support rigorous quality control and method validation processes. The available collection includes the active pharmaceutical ingredient alongside a comprehensive range of synthetic impurities, degradation products, and metabolites, such as nitroso and dehydro derivatives, essential for accurate impurity profiling during development and batch release. Additionally, researchers rely on stable isotope labelled compounds to ensure precision in mass spectrometry-based quantification and pharmacokinetic studies. By providing high-quality reference materials for these specific compounds, analytical chemists can effectively monitor product consistency and comply with stringent regulatory standards for safety and efficacy.